FEMY - Femasys obtains license to sell its products in Canada
2023-08-31 10:11:51 ET
More on Femasys
- Femasys stock dips on $3.9M equity offering
- Femasys rises on Canada approval of directional insemination product FemaSeed
- Femasys hits 52-week low, closes down 20% on significantly higher volume
- Femasys joins the Russell Microcap Index
- Seeking Alpha’s Quant Rating on Femasys
- Earnings data for Femasys
For further details see:
Femasys obtains license to sell its products in Canada